Metastatic Merkel Cell Carcinoma: Insights on the Clinical Application of Immune Checkpoint Inhibitors

Download All
This multifaceted program, which includes a module, interactive toxicity management algorithm tool, summary resource guide, and expert commentaries, equips clinicians with evidence-based insights on how to incorporate immune checkpoint inhibitors into clinical management of patients with metastatic Merkel cell carcinoma.
Shailender Bhatia, MD
Sandra P. D'Angelo, MD
Evan J. Lipson, MD
Paul Nghiem, MD

Module

Experts review current data on immunotherapies and provide their perspectives on optimal management of patients with metastatic Merkel cell carcinoma.

Shailender Bhatia, MD Sandra P. D'Angelo, MD Evan J. Lipson, MD Paul Nghiem, MD Physicians: maximum of 2.25 AMA PRA Category 1 Credits Released: February 22, 2017 Expired: No longer available for credit

In this downloadable slideset, distinguished faculty members Paul Nghiem, MD; Shailender Bhatia; MD, Sandra P. D’Angelo, MD; and Evan J. Lipson, MD, review key data and current practice changes in the treatment of advanced MCC. For additional in-depth analysis of the slideset, please review the accompanying CME-certified text module.

Released: February 22, 2017
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

This activity is supported by an educational grant from
Pfizer Inc.
Merck KGaA

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue